CHICAGO - Between the panels, the presentations and the partnering meetings, days spent at the BIO 2010 annual convention can feel pretty long. But the nights are longer. (BioWorld Today - 2010 BIO) Read More
CHICAGO - The 1998 discovery that - contrary to all previous teaching - the brain continues to generate neurons throughout life, is now being translated through to new drugs for treating depression and neurodegenerative diseases, attendees at the Biotechnology Industrial Organization annual conference were told Thursday. (BioWorld Today - 2010 BIO) Read More
CHICAGO - Before the so-called genomics bubble burst, it seemed any company with the word "genomics" in its name was a sure winner with investors, and the "average" biotech was able to stay afloat in both public and private markets. (BioWorld Today - 2010 BIO) Read More
Investors Thursday drove shares of Keryx Biopharmaceuticals Inc. up 6.8 percent after the firm said it started a short-term Phase III study evaluating Zerenex (ferric citrate), an iron-based phosphate binder, as a treatment for hyperphosphatemia in dialysis patients with end-stage renal disease (ESRD). (BioWorld Today) Read More
